Nonnucleoside reverse transcriptase inhibitors

Xiangyi Jiang, Boshi Huang, Shawn Rumrill, David Pople, Waleed A. Zalloum, Dongwei Kang, Fabao Zhao, Xiangkai Ji, Zhen Gao, Lide Hu, Zhao Wang, Minghui Xie, De Clercq Erik, Francesc X. Ruiz, Eddy Arnold, Christophe Pannecouque, Xinyong Liu, Peng Zhan

Article2002

Prediction of Activity for Nonnucleoside Inhibitors with HIV-1 Reverse Transcriptase Based on Monte Carlo Simulations

Robert C. Rizzo, Marina Udier–Blagović, Deping Wang, Edward K. Watkins, Marilyn B. Kroeger Smith, Richard H. Smith, Julian Tirado‐Rives, William L. Jorgensen

Journal of Medicinal Chemistry

Article2019

Fragment hopping-based discovery of novel sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 nonnucleoside reverse transcriptase inhibitors

Sheng Han, Ya-Li Sang, Yan Wu, Yuan Tao, Christophe Pannecouque, De Clercq Erik, Chunlin Zhuang, Fen‐Er Chen